TY - BOOK
T1 - A National Cancer Clinical Trials System for the 21st century
T2 - Reinvigorating the NCI Cooperative Group Program
AU - Committee on Cancer Clinical Trials and the NCI Cooperative Group Program
AU - Board on Health Care Services
AU - Institute of Medicine
AU - Nass, Sharyl J.
AU - Moses, Harold L.
AU - Mendelsohn, John
N1 - Publisher Copyright:
© 2010 by the National Academy of Sciences. All rights reserved.
PY - 2010/8/8
Y1 - 2010/8/8
N2 - The National Cancer Institute's (NCI) Clinical Trials Cooperative Group Program has played a key role in developing new and improved cancer therapies. However, the program is falling short of its potential, and the IOM recommends changes that aim to transform the Cooperative Group Program into a dynamic system that efficiently responds to emerging scientific knowledge; involves broad cooperation of stakeholders; and leverages evolving technologies to provide high-quality, practice-changing research.
AB - The National Cancer Institute's (NCI) Clinical Trials Cooperative Group Program has played a key role in developing new and improved cancer therapies. However, the program is falling short of its potential, and the IOM recommends changes that aim to transform the Cooperative Group Program into a dynamic system that efficiently responds to emerging scientific knowledge; involves broad cooperation of stakeholders; and leverages evolving technologies to provide high-quality, practice-changing research.
UR - http://www.scopus.com/inward/record.url?scp=85014152047&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85014152047&partnerID=8YFLogxK
U2 - 10.17226/12879
DO - 10.17226/12879
M3 - Book
C2 - 25032387
AN - SCOPUS:85014152047
SN - 0309151864
SN - 9780309151863
BT - A National Cancer Clinical Trials System for the 21st century
PB - National Academies Press
ER -